Economic and Humanistic Burden of Moderate and Severe Hemophilia A and B in Spain: Real-World Evidence Insights from the CHESS II Study
Author:
Affiliation:
1. Pfizer S.L.U., Madrid, Spain
2. Pharmacoeconomics and Health Outcomes Research Iberia (Spain)
3. HCD Economics, Daresbury, UK
4. University of Chester, Chester, UK
5. Pfizer Inc., New York, New York, USA
6. Pfizer Inc., New York, NY, USA
Abstract
Publisher
The Journal of Health Economics and Outcomes Research
Reference33 articles.
1. Guías españolas para el manejo del paciente con hemofilia;M.T. Álvarez,2022
2. The impact of extended half-life factor concentrates on prophylaxis for severe hemophilia in the United States;Lynn M. Malec;American Journal of Hematology,2020
3. Effect of late prophylaxis in hemophilia on joint status: a randomized trial;M.J. Manco-Johnson;Journal of Thrombosis and Haemostasis,2017
4. Interrelationship between depression, anxiety, pain, and treatment adherence in hemophilia: results from a US cross-sectional survey;Michelle L. Witkop;Patient Preference and Adherence,2019
5. The relationship between target joints and direct resource use in severe haemophilia;Jamie O’Hara;Health Economics Review,2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3